பாஸ்கல் நீகெண் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பாஸ்கல் நீகெண். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பாஸ்கல் நீகெண் Today - Breaking & Trending Today

Helix BioPharma Corp. Announces Changes to the Company's Board of Directors and Management

Helix BioPharma Corp. Announces Changes to the Company's Board of Directors and Management
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Richmond Hill , Frank Michalargias , Heman Chao , Pascal Nigen , Alpha Bronze , Toronto Stock Exchange , Helix Biopharma Corp , Board Of Directors The Company , Company Scientific Advisory Board , Helix Biopharma , Chief Executive Officer , Chief Scientific Officer , Scientific Advisory , Chief Financial , Looking Statements , Annual Information Form , ரிச்மண்ட் மலை , அவன் மனிதன் குழப்பம் , பாஸ்கல் நீகெண் , ஆல்பா வெண்கலம் , டொராண்டோ ஸ்டாக் பரிமாற்றம் , பலகை ஆஃப் இயக்குநர்கள் தி நிறுவனம் , தலைமை நிர்வாகி அதிகாரி , தலைமை அறிவியல் அதிகாரி , தலைமை நிதி , பார்க்கிறது அறிக்கைகள் ,

Helix BioPharma Corp. Announces Appointment of New Auditor and Extends Period to Exercise Warrants

Helix BioPharma Corp. Announces Appointment of New Auditor and Extends Period to Exercise Warrants
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Richmond Hill , Frank Michalargias , Pascal Nigen , Alpha Bronze , Toronto Stock Exchange , Helix Biopharma Corp , Helix Biopharma , Chief Financial , Looking Statements , Annual Information Form , ரிச்மண்ட் மலை , பாஸ்கல் நீகெண் , ஆல்பா வெண்கலம் , டொராண்டோ ஸ்டாக் பரிமாற்றம் , தலைமை நிதி , பார்க்கிறது அறிக்கைகள் , ஆண்டு தகவல் வடிவம் ,

Helix BioPharma Corp. Announces Fiscal Third Quarter 2021 Results

Helix BioPharma Corp. Announces Fiscal Third Quarter 2021 Results
OVERVIEW
The Company reported a net loss and total comprehensive loss of $2,554,000 and $5,268,000 for the three and nine-month periods ended April 30, 2021. For the three and nine-month periods ended April 30, 2020, net loss and total comprehensive loss totalled $2,489,000 and $6,896,000, respectively. The net loss and total comprehensive loss for the three-month period ending April 30, 2021, includes a net loss of $nil (2020 - $198,000) and for the nine-month period ending April 30, 2021 a gain of $1,536,000 (2020 - loss of $465,000) from discontinued operations. The Company lost control of its subsidiary in Poland during the three-month period ending October 31, 2020 though continued to exert significant influence until December 22, 2020 when the Company disposed of its remaining interest for gross proceeds of $2,308,000. ....

Richmond Hill , Frank Michalargias , Pascal Nigen , Helix Biopharma Corp , Company Interim Condensed Statement Of Financial Position , Company Interim Condensed Financial , Fund Management , Moffit Cancer Centre , Alpha Bronze , Company Interim Condensed Statement Of Net Loss , Lind Global Macro Fund , Helix Biopharma , Investigational New Drug , Multijurisdictional Disclosure System , Accounting Oversight Board , Consulting Management , Convertible Security , Interim Condensed Statement , Net Loss , Comprehensive Loss , Condensed Statements , Financial Position , Interim Condensed Financial Statements , Chief Financial , Looking Statements , Annual Information Form ,

Helix BioPharma Corp. Announces Institutional Investment for Gross Proceeds of up to CAD$10 million

Helix BioPharma Corp. Announces Institutional Investment for Gross Proceeds of up to CAD$10 million
RICHMOND HILL, ON / ACCESSWIRE / May 11, 2021 / Helix BioPharma Corp.(TSX:HBP)( Helix or the Company ), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has entered into a definitive convertible security funding agreement (the Agreement ) with Lind Global Macro Fund, LP, a New York based institutional investment fund managed by The Lind Partners, LLC (together, Lind ). Under the terms of the Agreement, an initial CAD$3.5 million will be funded pursuant to the issuance of a convertible security (a Convertible Security ) which is expected to occur on or around May 12, 2021 ( First Tranche ). The Agreement also contemplates the issuance of a second Convertible Security upon the mutual agreement of the Company and Lind for gross proceeds to the Company of up to CAD$6.5 million (the Second Tranc ....

New York , United States , United Kingdom , Richmond Hill , Frank Michalargias , Pascal Nigen , Company Common , Alpha Bronze , Toronto Stock Exchange , Helix Biopharma Corp , Lind Partners , Lind Global Macro Fund , Convertible Security , First Tranche , Second Tranche , Convertible Securities , Common Shares , Common Share , Toronto Stock , Chief Financial , Looking Statements , Annual Information Form , Helix Biopharma , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் ,

Dore Copper Mining to Present at Alpha Bronze Virtual Town Hall

Dore Copper Mining to Present at Alpha Bronze Virtual Town Hall
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Town Hall , Pascal Nigen , Alpha Bronze , Copper Mining , Alpha Bronze Virtual Town Hall , Ernest Mast , Chief Executive Officer , Virtual Town Hall , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , நகரம் மண்டபம் , பாஸ்கல் நீகெண் , ஆல்பா வெண்கலம் , தாமிரம் சுரங்க , ஆல்பா வெண்கலம் மெய்நிகர் நகரம் மண்டபம் , அர்நெஸ்ட் மாஸ்ட் , தலைமை நிர்வாகி அதிகாரி , மெய்நிகர் நகரம் மண்டபம் ,